























Rapid activation of brainstem nuclei following  
TLR stimulation of the nasal mucosa
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We recently identified a novel neuroimmune mechanism in the nasal mucosa, in which activation of neuronal Toll‑like receptor (TLR) 7 
results in upregulation of epithelial TLRs, via release of substance P. In the present study, we assessed whether intranasal challenge with 
the TLR7 agonist R‑837 additionally activated neurons in the central nervous system. Within one hour, R‑837 induced activation of the 
nucleus of the solitary tract, as well as a small increase in nasal IL‑6, but otherwise in the absence of an overt inflammatory response. 
It is tempting to speculate that it might be a direct interaction of R‑837 with trigeminal neurons in order to alert the central nervous 
system of invading pathogens.
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INTRODUCTION
The complex interaction between the nervous sys‑
tem and the immune system is a constantly growing 
field of research. Numerous studies have highlighted 
the multifaceted interplay between the peripheral ner‑
vous system (PNS) and the immune system, where neu‑
rotransmitters and neuropeptides can regulate inflam‑
matory mechanisms, and inflammatory mediators can, 
in turn, alter neuronal activity and sensitivity (Pavlov 
and Tracey, 2015). The well‑established field of neuro‑
immune communication has additionally outlined the 
cross‑talk between peripheral inflammation and the 
central nervous system (CNS), a protective strategy in 
which changes in CNS activity alter behaviour and lead 
to modulation of the immune system, to advance recov‑
ery following infection (D’Mello and Swain, 2017).
Toll‑like receptors (TLRs), a conserved family of 
pathogen recognition receptors, are responsible for 
the recognition of invading microorganisms, and are 
crucial to the development of an innate immune re‑
sponse (Kumar et al., 2011). Viruses are primarily rec‑
ognized via their pathogen‑associated molecular pat‑
terns (PAMPs) by the evolutionarily conserved family 
of TLRs, of which, amongst others, TLR7 is repsonsible 
for viral recognition (Xagorari and Chlichlia, 2008). 
Systemic activation of TLRs has long been known to 
lead to CNS activation, through the release of systemic 
pro‑inflammatory mediators, which communicate with 
the brain (D’Mello and Swain, 2017). Novel studies are 
now highlighting more direct interplay between TLRs 
and the nervous system. For example, numerous TLRs 
have been shown to be expressed on both peripheral 
and central neurons (Goethals et al., 2010; Drake et al., 
2013; Larsson et al., 2018), stimulation of which can 
both sensitize and activate neurons (Liu et al., 2010). In 
addition, neuronal mediators have the ability to modu‑
late the activity of TLRs (Goethals et al., 2010; Jiang et 
al. 2012). Further, TLRs expressed in the CNS have been 
shown to play a role in the early CNS development, and 
consequently, the development of psychiatric disorders 
(Chen et al., 2019; Haddad et al., 2020).
We recently published a study demonstrating that 
activation of sensory trigeminal neurons by the TLR7 
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agonist R‑837, led to a rapid release of substance P, and 
a consequent upregulation of epithelial TLRs (Larsson 
et al., 2018). This highlighted the role of neuronal TLRs 
in the protective response against invading pathogens. 
In the present study, we investigated whether TLRs 




Adult male C57BL/6 mice (6‑8 weeks) were obtained 
from Charles River (Sulzfeld, Germany). They were 
housed in plastic cages with adsorbent bedding in tem‑
perature and light‑dark cycle (12 h : 12 h) controlled 
rooms. Food and water were available ad libitum. Ani‑
mals were handled in accordance with the Federation 
for European Laboratory Animal Science Associations 
guidelines. All animal procedures were approved by the 
regional animal experimental ethical review board at 
Karolinska Institutet, Stockholm Sweden (ethical per‑
mit numbers: N153‑11 and N128‑13).
Nasal provocation
Mice were intranasally dosed with R‑837 
(20 µg/20 µl) or PBS under isoflurane anaesthesia. Fif‑
teen min, 30 min, 1 h and 3 h following provocation, 
animals were terminally anaesthetised with sodium 
pentobarbital (Apoteket AB, Sweden).
Nasal lavage 
Following euthanization, mouse tracheae were ex‑
posed, and small incision was made just below the lar‑
ynx. A 1 ml syringe containing 300 μl NAL buffer (PBS 
containing 30% proteinase inhibitor cocktail) attached 
to a 19 G needle was inserted into the trachea towards 
the nasal cavity and positioned at the epiglottis. Nasal 
lavage (NAL) buffer was flushed through the nasal cav‑
ity and collected. NAL was frozen on dry ice and stored 
at ‑80°C.
Immunohistochemistry
Following euthanization, animals were transcardi‑
ally perfused with heparinised saline followed by 4% 
freshly made paraformaldehyde (PFA) in 0.1 M phos‑
phate buffer. Brains were removed, post‑fixed in 4% PFA 
overnight, transferred to 30% sucrose for 24 h and sub‑
sequently embedded in OCT (TissueTek, Sukara Fintek, 
Göteborg, Sweden) and frozen in isopentane on dry ice.
Serial 40 µm sections from bregma ‑0.23 mm to breg‑
ma ‑8.15 mm were collected using a cryostat and stained 
free‑floating for cFos. Briefly, sections were quenched 
for endogenous peroxidase activity and blocked for 
non‑specific binding, using 1% H2O2 (Sigma‑Aldrich, 
St. Louis, MO, USA) and 3% normal goat serum, respec‑
tively. Sections were incubated with anti‑Fos antibody 
(1:20000) (PC38, Merck Millipore, Molsheim, France) for 
36 h, followed by a biotinylated goat anti‑rabbit anti‑
body (1:200) for 2 h and avidin‑biotin‑peroxidase com‑
plex for 2 h. Staining was visualised using nickel‑en‑
hanced 3,3’ diaminobenzidine. All reagents were pur‑
chased from Vector Laboratories (Peterborough, UK) 
unless otherwise specified.
Image analysis
Images were acquired on an Olympus Provis micro‑
scope (Olympus, Hamburg, Germany), connected to an 
Olympus U‑PS camera, using cellSens software (Olym‑
pus). Quantification of staining was performed using 
ImageJ. Image contrast was adjusted to the same value 
for all images. The area of interest was selected, and 
a particle count was performed. Particle size and cir‑
cularity was kept constant and was pre‑established ac‑
cording to an average size and circularity of particles 
from 10 figures. The area encompassing the nucleus of 
the solitary tract was cut out using the polygon out‑
line tool and pasted into a new 8‑bit ImageJ file. Images 
were thresholded to 165 or 185. Images from control 
animals were thresholded to the same threshold value 
as images from treated animals for the same round of 
staining. Particles were analysed based on size (10‑100) 
and circularity (0.25‑1.00).
Measurement of pro‑inflammatory cytokines
Levels of IL‑1β, IL‑6 and TNF‑α were measured in 
nasal lavage using a modified Bio‑Plex Pro Mouse Cy‑
tokine 23‑plex kit on a Luminex Instrument (BioRad), 
according to the manufacturer’s instructions.
Statistical analysis
Data were analysed using GraphPad Prism software 
(GraphPad Software, San Diego, California). Changes in 
cFos expression were assessed with a two‑way ANOVA 
followed by a Sidak’s multiple comparison post‑test 
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and alterations in inflammatory mediator production 
were assessed with non‑parametric Man‑Whitney U 
test. A p‑value of 0.05 or less was considered statisti‑
cally significant.
RESULTS
cFos expression following R‑837 challenge
To determine if stimulation of nasal TLR7 resulted 
in activation of the CNS, cFos expression was assessed 
15 min, 30 min, 1 h and 3 h after R‑837 challenge. No cFos 
expression could be detected 15 or 30 min post‑chal‑
lenge (data not shown). However, an increase in ex‑
pression was evident in the ipsi‑ and contralateral sides 
of the medial and caudal nucleus of the solitary tract 
(NTS) 1 h after challenge (Fig. 1A‑D). Quantification of 
staining (Fig. 1E) revealed a significant upregulation of 
staining following R837 challenge in the medial NTS, 
and a trend towards an increase in the caudal NTS. The 
expression had diminished by 3 h post‑challenge (data 
not shown).
Levels of pro‑inflammatory mediators  
following R‑387 challenge
It is well‑established that pro‑inflammatory medi‑
ators play a vital role in communication between the 
immune system and brain (D’Mello and Swain, 2017). 
To determine if R‑837 challenge was associated with 
local production of pro‑inflammatory mediators, lev‑
els of IL‑1β, TNF‑α and IL‑6 were assessed in NAL fol‑
lowing intranasal challenge with R‑837. Sixty minutes 
after challenge with R‑837, levels of IL‑6 were elevated 
(Fig. 2), as compared to PBS‑controls, reaching signifi‑
cance for IL‑6 (Fig. 2B). Comparatively, no differences 
in IL‑1β or TNF were evident (Fig. 2A, C).
DISCUSSION
We recently published a study indicating that ac‑
tivation of TLR7 on trigeminal neurons leads to rapid 
release of SP, which in turn upregulates TLRs on nearby 
epithelial cells (Larsson et al., 2018). This interaction 
between the PNS and TLRs acts to alert and prime the 
immune system for further pathogen invasion. In the 
present study we investigated whether the CNS played 
a parallel role in rapidly alerting and protecting the 
body from microbial assault.
Intranasal challenge with the TLR7 agonist R‑387 
led to activation of neurons in the NTS within one hour 
of challenge. Challenge was associated with elevated 
levels of nasal IL‑6, whereas no change in levels of IL‑1β 
or TNF‑α were apparent. The present study is the first 
to demonstrate that nasal challenge with TLR agonists 
leads to rapid activation of brainstem neurons.
The capacity for peripheral inflammatory signals 
to induce changes in the CNS, a process known as im‑
mune‑to‑brain communication, is by far not a nov‑
el concept. For many years, it has been known that 
systemic and local inflammation leads to activation 
of central neuronal pathways and de novo central im‑
mune mediator production, as well as fever and be‑
havioural changes, collectively termed “sickness be‑
haviour” (D’Mello and Swain, 2017). These changes are 
phycological, being necessary to allow the body to ap‑
propriately combat infection (Hart, 1988). Communi‑
cation is known to occur via two main routes: the hu‑
moral route involves the interaction of immune medi‑
355: 353–357
Fig. 1. cFos expression in the nucleus of the solitary (NTS) following intranasal R‑837 challenge. Animals were intranasally challenged with PBS (A, C) or 
R‑837 (B, D) and staining was assessed in the caudal (A‑B) and medial (C‑D) NTS after 1 h. Staining was quantified using image analysis software (E). Values 
are presented as mean +/‑ SEM. ***p<0.001 using a two‑way ANOVA followed by a Sidak’s multiple comparison post‑test; n=7.
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ators with cognate receptors at the blood‑brain barri‑
er (BBB), as well as direct entry of these mediators to 
circumventricular organs (CVOs); comparatively, the 
neuronal route involves interaction of immune me‑
diators with innervating sensory neurons. Numerous 
studies have indicated that peripheral immune stim‑
ulation leads to activation of neurons in many areas 
and of the brain, as well as behavioural alterations, 
within 3 h (Sagar et al., 1995). Activation diminishes 
within 6 h, but changes in neural circuitry and central 
immune mediator production lead to prolonged alter‑
ations in behaviour and mood (Dantzer et al., 2008).
In this study, intranasal challenge with R‑837 was 
associated with a different pattern of CNS activation. 
Activation was isolated to the brainstem, specifically 
the NTS, and was evident just one hour after challenge, 
disappearing within 3 h. Areas related to sickness be‑
haviour (e.g., paraventricular hypothalamus) were 
unaffected by R‑837 challenge. Interestingly, this is in 
contrast to previous studies that have identified chang‑
es in behavior (e.g. fever, decreased motor activity and 
depression), as well as activation of brain areas such 
as the area postrema, which were not apparent in this 
study (Hayasi et al., 2008; Damm et al., 2012; Kubo et 
al., 2013).
Activation of the CNS following immune stimulation 
is commonly explained by the production of local and 
systemic pro‑inflammatory cytokines and lipid medi‑
ators. Indeed, in previous studies, TLR7‑induced overt 
local and systemic inflammatory responses, leading to 
CNS activation via both neuronal and humoral routes. 
Results from the present study indicate that CNS activa‑
tion following R‑837 challenge likely occurs via a neu‑
ronal route of communication, and the involvement of 
inflammatory mediators is questionable. Nociceptive 
affarents from the nasal cavity project directly to the 
NTS (Anton and Peppel, 1991), suggesting that direct 
activation of these affarents, may be responsible for 
the rapid expression of cFos. Indeed the speed of acti‑
vation, as well as the lack of neuronal activation in sur‑
rounding CVOs, such as the area postrema, further dis‑
counts the involvement of humoral immune‑to‑brain 
communication.
In the present study, nasal mucosal levels of IL‑6 
were found to be elevated above control levels. How‑
ever, IL‑6 has been shown to sensitize sensory neurons 
(Andratsch et al., 2009; Durham et al. 2017), but not 
directly activate them. We and others have previously 
demonstrated that TLR7 is expressed on neurons in the 
nasal mucosa and respiratory tract (Drake et al., 2013; 
Larsson et al., 2018), and that TLR7 agonists can direct 
activate sensory neurons in culture (Dantzer et al., 
2008). This raises the possibility that R‑387 directly in‑
teracts with neurons in the nasal cavity to induce CNS 
activation. Indeed, the speed of activation in the CNS 
and the lack of relevant pro‑inflammatory cytokines in 
the nasal mucosa further corroborate this postulate.
As mentioned above, sensory neurons from the nasal 
cavity innervate the NTS. Retrograde labelling studies 
have also demonstrated that these neurons innervate 
a larger subset of nuclei, including the TBNC and SNC, 
and that stimulation with nasal irritants results in ac‑
tivation of these areas (Anton and Peppel, 1991) . How‑
ever, this study showed isolated activation of the NTS. 
One study has demonstrated that phasic stimulation of 
nasal nociceptors by CO2 leads to isolated activation of 
the NTS (Anton et al., 1991). The authors suggest that 
the lack of activation of all trigeminal nuclei was re‑
lated to low‑grade stimulation of peripheral affarents, 
indicating that R‑837 may induce low‑grade activation 
of trigeminal neurons.
The role of TLRs in the CNS is not limited to a role 
in infection and inflammation. Studies have highlight‑
ed the TLRs may play a role in early CNS development, 
particularly in neuronal morphogenesis. Chen et al. 
(2019) proposed that early activation of TLRs during 
CNS development may act as an alarm system to fa‑
cilitate neuronal morphogenesis. Indeed, studies have 
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Fig. 2. Levels of pro‑inflammatory cytokines in nasal lavage 1 h after intranasal challenge with PBS or R‑837. Levels were measured using a multiplex ELISA. 
Values are presented as individual data points.**p<0.001 using a non‑parametric Mann‑Whitney U‑test; n=8.
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shown that maternal TLR3 activation may alter mor‑
phogenesis and consequently lead to behavioural and 
psychiatric disorders in offspring (Haddad et al., 2020). 
It is clear that TLR activation in the CNS is crucial in 
many respects, and is worth further study. It is of inter‑
est to note that activation of the NTS has been linked 
to the development of cardiopulmonary reflexes. Due 
to the convergence of both trigeminal and vagal senso‑
ry afferents in this area, it is believed that activation of 
nociceptive neurons in the nasal cavity can induce va‑
gally‑mediated pulmonary reflexes, such as sneeze and 
apnea (Wallois et al., 1995). This response is protec‑
tive in nature, acting to eliminate irritating substances 
from the respiratory tract. The rapid activation of the 
NTS following R‑837 challenge may therefore indicate 
that the CNS is involved in the immediate protective 
response to eliminate invading pathogens.
CONCLUSIONS
The acquired data suggest that, in addition to the 
peripheral nervous system, the central nervous system 
plays a role in early recognition and possible elimi‑
nation of viral particles, and that direct activation of 
nerves by TLR agonists is likely involved in this process.
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